Drug Trial Radar · NCT01425359
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Last checked: Nov 20, 2026Latest source record: Nov 4, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
949
Actual
Start
Sep 2011
Primary completion
Oct 2012
Study completion Oct 2012
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- First posted
- Aug 30, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the effect of ranolazine compared to placebo on the average weekly angina frequency in subjects with chronic stable angina and coronary artery disease (CAD) who have a history of type 2 diabetes mellitus (T2DM), and whether ranolazine can reduce the frequency of angina (chest pain) attacks, compared to a placebo. Subjects will be asked to record their daily angina episodes in a diary at the end of each study day. Ranolazine is approved for the treatment of chronic angina, and is not approved for the treatment of T2DM.
Conditions
- Angina Pectoris
- Coronary Artery Disease
- Type 2 Diabetes Mellitus
Interventions
RanolazineDrug
Ranolazine placeboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average Weekly Angina Frequency Over the Last 6 Weeks of TreatmentTime frame: 6 weeks
Locations
135 sites in 14 countries. Site status is shown where the registry gives one.
Cardiology and Medicine Clinic
Little Rock, Arkansas
Merced Heart Associates
Merced, California
Spectrum Clinical Research Institute, Inc
Moreno Valley, California
Sacramento Heart and Vascular Research Center
Sacramento, California
South Florida Research Solutions, LLC
Hollywood, Florida
Baptist Heart Specialist
Jacksonville, Florida
Clinical Research of Central Florida
Winter Haven, Florida
Masters of Clinical Research, Inc.
Augusta, Georgia
Columbus Cardiology Associates
Columbus, Georgia
Central Cardiology Associates
Elizabethtown, Kentucky
Research Integrity, LLC
Owensboro, Kentucky
Alexandria Cardiology Clinic
Alexandria, Louisiana
Clinical Trials Management, LLC
Mandeville, Louisiana
Endeavor Medical Research, PLC
Alpena, Michigan
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota
Cross Country Cardiology
Edgewater, New Jersey
Kore CV Research
Jackson, Tennessee
Wellmont Cardiovascular Associates Heart Institute
Johnson City, Tennessee
Med-Tech Research
Houston, Texas
Humble Cardiology Associates
Humble, Texas
State Institution "Gomel regional clinical hospital"
Homyel, Belarus
State Inst Rep Scientific and Practical center
Minsk, Belarus
Diagnostic Consultative Center, Ascendent Cardiological Out-Patient Office
Sofia, Bulgaria
MHAT "Tsar Boris III"
Sofia, Bulgaria
National Cardiology Center, Cardiology Clinic - III
Sofia, Bulgaria
MHAT "Vita", Cardiology Department
Sofia, Bulgaria
UMHAT "Tsaritsa Yoanna" - ISUL, Cardiology Clinic
Sofia, Bulgaria
Military Medical Academy, Clinic of Cardiology and Intesive Care
Sofia, Bulgaria
High Desert Medical Group
Lancaster, Canada
Montreal Heart Institute
Montreal, Canada
London Road Diagnostic Clinic and Medical Centre
Ontario, Canada
Topsail Road Medical Clinic
St. John's, Canada
Dr. Roger Labonté Professional Medicine Corp.
Greater Sudbury, Ontario, Canada
SKDS Research Inc
Newmarket, Ontario, Canada
Aniol Gupta MD
Toronto, Ontario, Canada
Montréal General Hospital
Montreal, Quebec, Canada
Vojenska Nemocnice Brno
Brno, Czechia
Cardiocentrum Kladno s.r.o.
Kladno, Czechia
Poliklinika Modrany - Kardiologie
Prague, Czechia
Fakultní Nemocnice v Motole
Prague, Czechia
Showing 40 of 135 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.